Harm Seen in Alternative Treatments, Though Early Prostate Cancers Likely Exception, Study Says

Harm Seen in Alternative Treatments, Though Early Prostate Cancers Likely Exception, Study Says
Over the years, the side effects of radiation and chemotherapy have been studied and debated by physicians and questioned by cancer patients, some of whom have made turned to alternative treatments. A database study of four common cancers in the U.S. — breast, prostate, lung, and bowel — found that patients with non-metastatic cancer who declined "conventional treatments" were more likely to die within five years of diagnosis than those who undergo standard care — with the exception of low- and intermediate-risk prostate cancers not in need of extra care. The study by Skyler Johnson, a radiotherapy cancer specialist at Yale University,  was published in the Journal of the National Cancer Institute, under the title “Use of Alternative Medicine for Cancer and Its Impact on Survival.” Cancer patients have the right to decide which type of treatment they feel most comfortable with, but being well-informed as to the pros and cons of such treatments is crucial, and such information may not be readily available. To understand the potential harm of such alternatives, Johnson gathered data from cancer patients who opted for unconventional cancer therapies. He began investigating the issue on the web after his wife was diagnosed with Hodgkin's lymphoma, a type of blood cancer. "It was during my second year of medical school when my wife was diagnosed with Hodgkin lymphoma," he said in a
Subscribe or to access all post and page content.